News

MPR29m
Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Daily Graphic55m
FDA approves powerful HIV prevention drug: What to know about Yeztugo
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...